St. Jude Children’s Research Hospital is looking for participants in Memphis for a new clinical trial involving PrEP.
HPTN 083-01 is a clinical trial examining whether injectable cabotegravir (CAB) for PrEP (pre-exposure prophylaxis) is safe and acceptable for adolescent males (assigned male at birth –including transgender women (TGW), and gender-nonconforming people).
You may be eligible for this research study if:
- you are 17 years old and younger
- you are HIV uninfected
- you were assigned male at birth
- you have had or are interested in sexual experiences with male or transgender partners.
Participants will receive free and confidential HIV/STI testing, plus compensation for study procedures.
Get specific details about the study at inject2protect.org.
To learn more, please call or text the study staff at 901-216-1166 or email [email protected].
To find out your eligibility please scan the QR code below and complete the pre-screening questionnaire.
